Variant report
Variant | esv1831977 |
---|---|
Chromosome Location | chr8:120071144-120076264 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr8:120075536-120075888 | A549 | lung: | n/a | chr8:120075710-120075721 |
2 | CEBPB | chr8:120075550-120075883 | H1-hESC | embryonic stem cell: | n/a | chr8:120075710-120075721 |
3 | CEBPB | chr8:120075557-120075926 | ECC-1 | luminal epithelium: | n/a | chr8:120075710-120075721 |
4 | CEBPB | chr8:120073999-120074133 | A549 | lung: | n/a | chr8:120074022-120074033 |
5 | CEBPB | chr8:120075504-120076119 | Hela-S3 | cervix: | n/a | chr8:120075710-120075721 |
6 | CEBPB | chr8:120075529-120075904 | IMR90 | lung: | n/a | chr8:120075710-120075721 |
7 | CEBPB | chr8:120075495-120075927 | MCF-7 | breast: | n/a | chr8:120075710-120075721 |
8 | CEBPB | chr8:120075418-120075942 | MCF-7 | breast: | n/a | chr8:120075710-120075721 |
9 | CEBPB | chr8:120073950-120074092 | HepG2 | liver: | n/a | chr8:120074022-120074033 |
10 | CEBPB | chr8:120075550-120075781 | K562 | blood: | n/a | chr8:120075710-120075721 |
11 | CEBPB | chr8:120075554-120075934 | A549 | lung: | n/a | chr8:120075710-120075721 |
12 | CEBPB | chr8:120075533-120075898 | HepG2 | liver: | n/a | chr8:120075710-120075721 |
13 | CTCF | chr8:120071740-120071890 | HCM | heart: | n/a | n/a |
14 | CTCF | chr8:120071840-120071990 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr8:120071760-120071910 | HPAF | blood vessel: | n/a | n/a |
16 | CTCF | chr8:120075640-120075790 | Caco-2 | colon: | n/a | n/a |
17 | POLR2A | chr8:120073334-120073392 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr8:120074776-120074856 | A549 | lung: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:119884867..119886696-chr8:120073513..120075509,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TNFRSF11B-1 | chr8:120075181-120075479 | ENSG00000254278.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
COLEC10 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78198696 | chr8:120071145-120071146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556530696 | chr8:120071146-120071147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537718748 | chr8:120071170-120071171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556326935 | chr8:120071175-120071176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs60979638 | chr8:120071194-120071195 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs538825543 | chr8:120071214-120071215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542228946 | chr8:120071262-120071263 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553939986 | chr8:120071318-120071319 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188759790 | chr8:120071342-120071343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147316464 | chr8:120071367-120071368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2450084 | chr8:120071380-120071381 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs35944805 | chr8:120071390-120071391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546031483 | chr8:120071426-120071427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372660011 | chr8:120071479-120071480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200155198 | chr8:120071499-120071500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147055687 | chr8:120071501-120071502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369393540 | chr8:120071502-120071503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140713481 | chr8:120071504-120071505 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76006137 | chr8:120071514-120071515 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543695135 | chr8:120071523-120071524 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574279923 | chr8:120071575-120071576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1485314 | chr8:120071577-120071578 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs192012520 | chr8:120071600-120071601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533397100 | chr8:120071669-120071670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545177259 | chr8:120071704-120071705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77040901 | chr8:120071708-120071709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574746427 | chr8:120071710-120071711 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184568183 | chr8:120071715-120071716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567103709 | chr8:120071721-120071722 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531643180 | chr8:120071736-120071737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370464315 | chr8:120071738-120071739 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549848154 | chr8:120071763-120071764 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189278766 | chr8:120071823-120071824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139371021 | chr8:120071872-120071873 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182064012 | chr8:120071880-120071881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1485315 | chr8:120071898-120071899 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs370826764 | chr8:120071906-120071907 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566995133 | chr8:120071938-120071939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1385511 | chr8:120071939-120071940 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs555743267 | chr8:120071945-120071946 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184296497 | chr8:120071956-120071957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368711720 | chr8:120071957-120071958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112102332 | chr8:120072044-120072045 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75860192 | chr8:120072045-120072046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71532416 | chr8:120072077-120072078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1485316 | chr8:120072087-120072088 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs189586172 | chr8:120072203-120072204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560283474 | chr8:120072205-120072206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2465366 | chr8:120072214-120072215 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs373149235 | chr8:120072215-120072216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 20932292 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 22056952 | CNVD |
Langer-Giedion syndrome | 16773131 | CNVD |
Lung cancer | 16740712 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Langer-Giedion syndrome | 22470819 | CNVD |
Cornelia de Lange syndrome | 24599119 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Breast cancer | 18698023 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Uveal melanoma | 20484589 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Breast cancer | 19181860 | CNVD |
Endometrial cancer | 23636398 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 16397240 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:120067000-120076000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr8:120068200-120071200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr8:120070600-120071200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr8:120071200-120072400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr8:120074800-120076200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr8:120075200-120076400 | Enhancers | Fetal Lung | lung |
7 | chr8:120075200-120077200 | Enhancers | Hela-S3 | cervix |
8 | chr8:120075400-120075800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr8:120075400-120075800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr8:120075400-120075800 | Enhancers | Esophagus | oesophagus |
11 | chr8:120075400-120076200 | Enhancers | NHDF-Ad | bronchial |
12 | chr8:120075800-120078200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr8:120076000-120076200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr8:120076200-120079800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |